Nervous System Disorder linked to Reglan usage

Tardive dyskinesia, a syndrome that causes involuntary movements in the lower face, has been associated with the gastrointestinal drug, Reglan. Reglan is approved for short term (3 month) usage for the treatment of various gastrointestinal diseases. Common side effects include: repetitive chewing, lip smacking, jaw swinging, impaired finger movements, tongue thrusting and grimacing.

In February 2009, the FDA required that a “black box” warning about tardive dyskinesia be added to all packaging of Reglan products. Drug manufacturers are also required to implement a risk evaluation to ensure that patients receiving the drug are fully informed about the risk of developing the side effects.
If you or a loved one have been affected by Reglan, please contact Drug Alert Updates. We will be able to assist you with any questions that you may have and determine if you are eligible for compensation through a Reglan lawsuit.

  • Share/Bookmark

December 3, 2009  Tags: , ,   Posted in: Reglan

Leave a Reply


    no matches